Humana Inc Etf Earnings Per Share
| HUM Etf | USD 325.30 3.03 0.92% |
Humana Inc fundamentals help investors to digest information that contributes to Humana's financial success or failures. It also enables traders to predict the movement of Humana Etf. The fundamental analysis module provides a way to measure Humana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Humana etf.
Humana |
Humana Inc ETF Earnings Per Share Analysis
Humana's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Humana Earnings Per Share | 20.00 X |
Most of Humana's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Humana Inc has an Earnings Per Share of 20.0 times. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Health Care category. The earnings per share for all United States etfs is notably lower than that of the firm.
Humana Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in earnings per share as compared to similar ETFs.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0634 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 30.95 B | ||||
| Shares Outstanding | 120.55 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 94.21 % | ||||
| Number Of Shares Shorted | 2.45 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 2.32 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 106.44 B | ||||
| Gross Profit | 17.18 B | ||||
| EBITDA | 4.6 B | ||||
| Net Income | 2.49 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 12.27 B | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 1.53 X | ||||
| Book Value Per Share | 133.05 X | ||||
| Cash Flow From Operations | 3.98 B | ||||
| Short Ratio | 1.62 X | ||||
| Earnings Per Share | 20.00 X | ||||
| Price To Earnings To Growth | 1.64 X | ||||
| Target Price | 381.28 | ||||
| Number Of Employees | 67.6 K | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 39.58 B | ||||
| Total Asset | 46.89 B | ||||
| Retained Earnings | 27.54 B | ||||
| Working Capital | 366.27 M | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.64 % | ||||
| Net Asset | 46.89 B | ||||
| Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Humana Piotroski F Score and Humana Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.